Samsara BioCapital’s Allakos ALLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-172,089
| Closed | -$39.2K | – | 31 |
|
|
2025
Q1 | $39.2K | Hold |
172,089
| – | – | 0.01% | 36 |
|
|
2024
Q4 | $208K | Hold |
172,089
| – | – | 0.03% | 39 |
|
|
2024
Q3 | $112K | Hold |
172,089
| – | – | 0.02% | 38 |
|
|
2024
Q2 | $172K | Hold |
172,089
| – | – | 0.04% | 36 |
|
|
2024
Q1 | $217K | Hold |
172,089
| – | – | 0.03% | 35 |
|
|
2023
Q4 | $470K | Hold |
172,089
| – | – | 0.07% | 35 |
|
|
2023
Q3 | $391K | Hold |
172,089
| – | – | 0.12% | 36 |
|
|
2023
Q2 | $750K | Hold |
172,089
| – | – | 0.13% | 39 |
|
|
2023
Q1 | $766K | Hold |
172,089
| – | – | 0.16% | 42 |
|
|
2022
Q4 | $1.45M | Hold |
172,089
| – | – | 0.31% | 35 |
|
|
2022
Q3 | $1.05M | Hold |
172,089
| – | – | 0.25% | 42 |
|
|
2022
Q2 | $539K | Hold |
172,089
| – | – | 0.14% | 49 |
|
|
2022
Q1 | $981K | Hold |
172,089
| – | – | 0.25% | 45 |
|
|
2021
Q4 | $1.69M | Hold |
172,089
| – | – | 0.33% | 38 |
|
|
2021
Q3 | $18.2M | Buy |
172,089
+25,830
| +18% | +$2.31M | 2.86% | 10 |
|
|
2021
Q2 | $12.5M | Hold |
146,259
| – | – | 1.54% | 17 |
|
|
2021
Q1 | $16.8M | Hold |
146,259
| – | – | 3.1% | 9 |
|
|
2020
Q4 | $20.5K | Sell |
146,259
-46,075
| -24% | -$4.8M | 2.06% | 7 |
|
|
2020
Q3 | $15.7M | Sell |
192,334
-51,534
| -21% | -$4.18M | 4.37% | 8 |
|
|
2020
Q2 | $17.5M | Sell |
243,868
-27,097
| -10% | -$1.82M | 5.64% | 6 |
|
|
2020
Q1 | $12.1M | Buy |
270,965
+28,460
| +12% | +$1.95M | 6.94% | 5 |
|
|
2019
Q4 | $23.1M | Sell |
242,505
-44,700
| -16% | -$3.93M | 11.08% | 3 |
|
|
2019
Q3 | $22.6M | Sell |
287,205
-159,700
| -36% | -$10.5M | 15.37% | 2 |
|
|
2019
Q2 | $18.9M | Hold |
446,905
| – | – | 12.47% | 3 |
|
|
2019
Q1 | $18.1M | Sell |
446,905
-11,461
| -3% | -$463K | 14.22% | 2 |
|
|
2018
Q4 | $24M | Buy |
+458,366
| New | +$23M | 23% | 1 |
|
Samsara BioCapital's ALLK Position: Q2 2025 in Review
Samsara BioCapital sold out of Allakos (ALLK) in Q2 2025, closing a stake of 172,089 shares — an estimated $39.2K sold.
Samsara BioCapital first reported a position in ALLK in Q4 2018 and held it in 26 quarters. The position peaked at $24M in Q4 2018. 0 funds tracked by Wall St. Rank hold ALLK as of Q2 2025.
- Samsara BioCapital reported no remaining Allakos position as of Q2 2025 after selling out during the quarter.
- Samsara BioCapital sold 172,089 Allakos shares in Q2 2025, an estimated $39.2K.
- Samsara BioCapital first reported a position in Allakos in Q4 2018 and held it in 26 quarters.
- Samsara BioCapital's Allakos position peaked at $24M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Allakos as of Q2 2025.
Based on Samsara BioCapital's 13F filing for Q2 2025, filed 14 Aug 2025.